Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca98bccfbed5b5910fceebf9e744da85 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
filingDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c87e15d05310e681edf1286dfbd10a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68774b36d9e66678632fca09079cb8e1 |
publicationDate |
2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019052176-A |
titleOfInvention |
Drugs for the treatment of hyperbilirubinemia or its symptoms in infants, containing stannsoporfin |
abstract |
Disclosed is a drug for the treatment of hyperbilirubinemia or symptoms thereof in infants. Administering a therapeutic amount of stannsoporfin to an infant with hyperbilirubinemia in which at least one baseline total bilirubin level exceeds a predetermined threshold and at least one risk factor is present, and One risk factor is hemolytic disease, and the predetermined threshold is 1 to 3 mg / dL below the threshold for phototherapy administration according to the 2004 AAP nomogram corresponding to infant age, and the therapeutic dose of stannsoporfin is 0.75 mg / kg to 5 mg / kg on the basis of the body weight. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019147034-A |
priorityDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |